Delivery Order SPE2DB22D1017-SPE2DB25FG8FM
- Not listed
- The Defense Logistics Agency awarded a $1,436.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,111.23 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $7,418.26, represents a non-competitive set-aside award and is scheduled for completion by July 21, 2025. The pharmaceutical product will be delivered to the prime contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a $3,145.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of Terbinafine HCl 250 mg tablets, with a period of performance through July 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which enables...
- This delivery order, awarded July 21, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Terbinafine HCL 250 mg tablets in quantities of 100 units, with a ceiling value of $11,615.45 and a completion date of July 22, 2025. The contract utilizes firm fixed pricing and is not designated as a set-aside award, indicating that it was competitively procured. Performance will be fulfilled from AmerisourceBergen Drug Corp's corporate office location in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,050.91, is for the delivery of Terbinafine HCL 250 mg tablets. The contract is a firm-fixed-price delivery order with a performance period ending on May 8, 2025. This order is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,958.45 firm fixed-price contract is for the delivery of Terbinafine HCL 250 mg tablets. The contract has a completion date of July 8, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,163.16, is a Delivery Order for 4,566,761,020 units of Terbinafine HCL 250 mg tablets with a completion date of December 19, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,186.62, is a delivery order for the supply of 4,567,039,299 units of Terbinafine HCL 250 mg tablets. The contract has a firm fixed price and an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $12,222.99 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Terbinafine HCL 250 mg tablets, with a period of performance through July 3, 2025. The contract is not set-aside and was awarded as a standalone delivery order, rather than under a larger contract vehicle. AmerisourceBergen Drug Corp is a key supplier of pharmaceuticals and medical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8FMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $42,212 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 100 units. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of July 28, 2025. The contract was executed on July 25, 2025, with performance to be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles established by the DLA Troop Support's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.2k | 7/25/25 |